Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Pulse Biosciences (PLSE) Cost of Revenue (2021 - 2025)

Historic Cost of Revenue for Pulse Biosciences (PLSE) over the last 3 years, with Q3 2025 value amounting to $279000.0.

  • Pulse Biosciences' Cost of Revenue changed N/A to $279000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $279000.0, marking a year-over-year change of. This contributed to the annual value of $11.9 million for FY2022, which is 50691.06% up from last year.
  • According to the latest figures from Q3 2025, Pulse Biosciences' Cost of Revenue is $279000.0.
  • In the past 5 years, Pulse Biosciences' Cost of Revenue registered a high of $8.4 million during Q3 2022, and its lowest value of $279000.0 during Q3 2025.
  • Its 3-year average for Cost of Revenue is $2.0 million, with a median of $1.2 million in 2021.
  • Within the past 5 years, the most significant YoY rise in Pulse Biosciences' Cost of Revenue was 105543.33% (2022), while the steepest drop was 402.9% (2022).
  • Over the past 3 years, Pulse Biosciences' Cost of Revenue (Quarter) stood at $1.2 million in 2021, then rose by 4.03% to $1.3 million in 2022, then plummeted by 78.39% to $279000.0 in 2025.
  • Its last three reported values are $279000.0 in Q3 2025, $1.3 million for Q4 2022, and $8.4 million during Q3 2022.